Project description
Innovative detection system for road safety
Fatigue, alcohol consumption and narcotics intake cause fatal road accidents as well as occupational accidents affecting society, infrastructure, healthcare and the economy in the EU. However, tests for road users and safety-critical professions are rare, and a reliable fatigue detection system is not available. The pupillary light reflex is one of the most relevant indicators of fatigue and drug consumption. The EU-funded Stellar i-ris project presents the first non-invasive, reliable and quick method that can detect fatigue as well as the presence of narcotics in the system using a unique process and algorithm for the biometric measurement of the human pupil light reflex. The innovation includes closed measurement glasses with infrared retina illumination targeted at controllers and a self-detection smartphone application for users.
Objective
Stellar i-ris aims to prevent and reduce accidents on roads and at safety-critical workplaces due to users’ fatigue and narcotics (incl. alcohol, drugs, psychoactive medicine) intake. In the past 10 years, 376,343 fatal road accidents were reported in the EU. These accidents cause even more injuries and cost at the global level 1-3% of the world’s GDP. Occupational accidents cause 350,000 deaths /year and millions of serious injuries worldwide. It is estimated that drivers’ fatigue and narcotics intake cause approx. 27% of fatal road accidents. This has dramatic effects on our economy, society, infrastructure and healthcare systems. Yet for time and cost reasons, road users and safety-critical professions are tested very rarely. Scientifics estimate a high “hidden” number of cases of fatigue and driving under the influence (DUI) of narcotics. This is due to the absence of reliable, all-in-one tests on the market. No fatigue detection system is currently used by traffic authorities. The pupillary light reflex - a recognised marker for fatigue and narcotics - is one of the most relevant indicators. Current detection systems are not economically viable or present technical drawbacks (analysis time, accuracy, invasiveness, heavy equipment). Company Stellar offers the first non-invasive, reliable and quickest fatigue and narcotics detection system using a unique process and algorithm for the biometric measurement of the human pupil light reflex. It includes 2 product concepts: i-risHEAD, closed measurement glasses with IR-retina illumination, targeted to controllers (traffic authorities, OHS specialists, employers) and i-risLIGHT, a self-detection smartphone application, targeted to end users (drivers, workers at safety-critical workplaces). The innovation targets the markets of drug-of-abuse and fatigue testing in Europe – together estimated at €1 billion. Stellar i-ris will largely contribute to our company growth: €30M additional turnover and 87 new employees by 2023.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
- natural sciencescomputer and information sciencessoftware
- engineering and technologymaterials engineering
- natural scienceschemical sciencesorganic chemistryalcohols
- engineering and technologyelectrical engineering, electronic engineering, information engineeringinformation engineeringtelecommunicationsmobile phones
- medical and health scienceshealth sciencespublic healthoccupational health
You need to log in or register to use this function
Programme(s)
Funding Scheme
SME-2 - SME instrument phase 2Coordinator
50354 HURTH
Germany
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.